We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Relationship Between Serum Adiponectin and Clinical Prognosis in Patients Undergoing Cardiac Surgery

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2011 by Xijing Hospital.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01393535
First Posted: July 13, 2011
Last Update Posted: July 13, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Xijing Hospital
  Purpose
The purpose of this study is to investigate the relationship between serum adiponectin and clinical prognosis in patients undergoing cardiac surgery.

Condition
Cardiac Surgery

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Study of the Relationship Between Serum Adiponectin and Clinical Prognosis in Patients Undergoing Cardiac Surgery

Resource links provided by NLM:


Further study details as provided by Xijing Hospital:

Estimated Enrollment: 800
Study Start Date: July 2011
Estimated Study Completion Date: August 2012
Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Detailed Description:
Adiponectin, an adipose tissue derived protein, is an abundant protein hormone regulatory of numerous metabolic processes. Since its discovery, adiponectin has garnered considerable attention for its role in cardiovascular pathology. It has been shown to be a predictor of cardiovascular events in both the general population and patients undergoing cardiac surgery. In this study,we are planning to investigate the relationship between serum adiponectin and clinical prognosis in patients undergoing cardiac surgery.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients underwent cardiac surgery in cardiovascular surgery department of xijing hospital.
Criteria

Inclusion Criteria:

  • Patients who had underwent cardiac surgery from July 2011 to August 2012 in xijing hospital.

Exclusion Criteria:

  • Nothing particular.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01393535


Contacts
Contact: Chunhu Gu, MD guchunhu@fmmu.edu.cn

Locations
China, Shannxi
Xijing Hospital Not yet recruiting
Xi'an, Shannxi, China, 710032
Contact: Chunhu Gu, MD       guchunhu@fmmu.edu.cn   
Principal Investigator: Chunhu Gu, MD         
Principal Investigator: Yukun Cao, MD         
Sponsors and Collaborators
Xijing Hospital
Investigators
Study Chair: Dinghua Yi, MD Xijing Hospital
  More Information

Responsible Party: Chunhu Gu, Xijing Hospital
ClinicalTrials.gov Identifier: NCT01393535     History of Changes
Other Study ID Numbers: Guch-013
First Submitted: July 11, 2011
First Posted: July 13, 2011
Last Update Posted: July 13, 2011
Last Verified: July 2011

Keywords provided by Xijing Hospital:
Adiponectin
Prognosis
Cardiac Surgery